Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Diagnostic
- Drugs
- Biotechnology
- Diagnostic Substances
- Disease
- Medical
- Scientific & Technical Instruments
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 10350
License Grant
The Developer, government organization, of rapid saliva testing products, has enhanced its exclusive, worldwide license for the flow immunosensor technology (FIT).
Licensor grants to an exclusive right and license to practice the licensed invention throughout the United States and in the licensed territory in the field of saliva based human diagnostics and urine based testing for drugs of abuse and urine based testing for Methadone, Benzodiazapines Barbituates, Propoxyphene, Tricyclic Antidepressants and Anabolic Steroids.
License Property
FIT is a kinetic immunoassay that provides rapid diagnostic testing results onsite.
Licensor has an assignment of title to the invention disclosed and claimed in U.S. Patent Application Serial No. 07/486,024, and U.S. Patent No. 5,183,740 for Flow Immunosensor Method and Apparatus.
Field of Use
The agreement expands the field of use from drugs of abuse and anabolic steroids on urine samples to include all possible diagnostic uses for saliva.
IPSCIO Record ID: 2965
License Grant
LICENSOR, government organization, agrees to and does hereby grant to LICENSEE an exclusive right and license to practice the licensed invention throughout the United States and in the Licensed Territory in the field of drugs of abuse and in the field of testing for Methadone, Benzodiazapines Barbituates, Propoxyphene, Tricyclic, Antidepressants and Anabolic Steroids for a period of ten (10) years commencing on the date of execution of this Modification by LICENSOR, which shall become the effective date of the LICENSE, and a nonexclusive right and license to practice the licensed invention after completion of that ten (10) year period until the expiration of licensed patents unless the LICENSE is sooner modified or terminated in whole or in part.
License Property
The Licensed technology reates to the practice the invention of Patent No. 5,354,654 entitled “Lyophilized Ligand-Receptor Complexes for Assays and Sensors†dated October 11, 1994 in the field of Drugs of Abuse and in the field of testing for Methadone, Benzodiazapines, Barbituates, Propoxyphene, Tricyclic, Antidepressants and Anabolic Steroids.
IPSCIO Record ID: 29033
License Grant
Licensor and Licensee signed a world-wide License Agreement for Licensor's RapidSense technology, specifically for the purpose of making, using and offering for sale saliva tests for Drugs of Abuse.
License Property
RapidSense(R) is a patented technology – a one-step lateral flow test with unique features such as positive read indication for Drugs of Abuse, improved sensitivity, and the ability to read both large and small molecules. The rapid, disposable and point-of-care diagnostic technology is ideal for collection of either urine or oral fluids.
IPSCIO Record ID: 1150
License Grant
The Licensor granted an exclusive, worldwide license to the relevant Diagnostic Technology.
Diagnostic Technology means any information, inventions, and discoveries made, conceived, derived, or otherwise reduced to practice by Licensor related to the Field.
License Property
U.S. Patent No. 5,516,638 Immunoassays for the Detection of Antibodies to Chlamydia Trachomatis in the Urine.
Field of Use
Field of Use means any urine-based medical diagnostic test.
IPSCIO Record ID: 2386
License Grant
The Licensor, an individual, and the Licensee desire to hereby amend and restate the Original Agreement in its entirety to clarify certain rights and obligations of the parties from and after March 1, 1997.
License Property
Licensor owns U.S. Patent No. 5,516,638 Immunoassays for the Detection of Antibodies to Chlamydia Trachomatis in the Urine. Issued May 14, 1996.
Field of Use
The Field means any urine-based medical diagnostic test.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
